• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SHIRAKAWA OLYMPUS CO., LTD. ULTRASONIC PROBE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SHIRAKAWA OLYMPUS CO., LTD. ULTRASONIC PROBE Back to Search Results
Model Number UM-G20-29R
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Pancreatitis (4481)
Event Date 02/09/2023
Event Type  Injury  
Manufacturer Narrative
The device was not returned to olympus for evaluation.The literature article is attached for additional information.Doi.Org/10.1016/j.Gie.2023.02.005 provided for additional information.The investigation is ongoing, and a supplemental report will be submitted upon completion of the investigation or if any additional information is provided.
 
Event Description
Olympus reviewed the literature titled "innovative method for the diagnosis of bile duct lesions using a novel tapered-tip sheath system to facilitate biliary biopsies." background and aims: pathologic evaluation of bile duct lesions is crucial for a definitive diagnosis and determination of an appropriate therapeutic strategy; however, current methods are limited by several challenges.This study evaluated the impact of a novel tapered-tip sheath system on biliary stricture diagnosis.Methods: this observational study evaluated 47 consecutive patients who underwent transpapillary biliary stricture biopsy using the novel tapered-tip sheath system from july 2020 to march 2022 compared with 51 historical control subjects undergoing conventional biopsies.Technical success rate, total biopsy time, number of biopsy specimens, adequate tissue sampling rate, adverse events, and diagnostic performance for biliary strictures were assessed.Results: the technical success rate was favorable in both groups, showing no significant difference (97.9% [46 of 47] vs 88.2% [45 of 51], p z.114).However, the total biopsy time was significantly shorter in the novel system group (3.7 vs 7.7 minutes, p <.001).The number of biopsy specimens did not differ between the groups; however, the novel system group had significantly more cases in which 3 tissue samples could be obtained (71.7% [33 of 46] vs 51.1% [23 of 45], p z.043), a higher adequate tissue sampling rate (88.2% vs 66.4%, p <.001), and fewer adverse events (6.4% vs 21.6%, p z.043).Although the diagnostic specificity of both groups was 100%, the novel system group had significantly higher diagnostic sensitivity and accuracy (82.1% vs 50% [p z.004] and 84.8% vs 55.5% [p z.005], respectively).Conclusions: the novel tapered-tip sheath system is a promising tool for biliary stricture diagnosis.Type of adverse events/number of patients: acute pancreatitis (mild=10, moderate=1, severe=2) cholangitis (1) there are three related patient identifiers: (b)(6) :tjf-260v (evis lucera duodenovideoscope) (b)(6) :chf-b260 (evis lucera ultrathin videoscope) (b)(6) :um-g20-29r (ultrasonic probe) this medwatch is for (b)(6).
 
Manufacturer Narrative
This report is being supplemented to provide additional information based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, the relationship between the device and the adverse events cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
 
Manufacturer Narrative
This report is being supplemented to provide additional information received from the author b5.
 
Event Description
Additional information received from the author: the reported events were not caused by olympus products.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRASONIC PROBE
Type of Device
ULTRASONIC PROBE
Manufacturer (Section D)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima 961-8 061
JA  961-8061
Manufacturer (Section G)
SHIRAKAWA OLYMPUS CO., LTD.
3-1 okamiyama
odakura, nishigo-mura,
nishishirakawa-gun, fukushima
Manufacturer Contact
todd brill
800 west park drive
westborough, MA 01581
5082077661
MDR Report Key18647900
MDR Text Key334620945
Report Number3002808148-2024-01118
Device Sequence Number1
Product Code ITX
UDI-Device Identifier04953170078668
UDI-Public04953170078668
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K001203
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Literature,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 03/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberUM-G20-29R
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 01/10/2024
Initial Date FDA Received02/05/2024
Supplement Dates Manufacturer Received03/12/2024
03/14/2024
Supplement Dates FDA Received03/12/2024
03/19/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Treatment
CHF-B260 (EVIS LUCERA ULTRATHIN VIDEOSCOPE).; TJF-260V (EVIS LUCERA DUODENOVIDEOSCOPE).
Patient Outcome(s) Other;
-
-